Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Altamira Therapeutics Ltd. (CYTOF) Return on Tangible Equity data is not available for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$0.52M |
|
$0.00M |
|
$7.55M |
|
$8.07M |
|
$1.23M |
|
-- |
|
$0.52M |
|
$1.75M |
|
$6.32M |
|
$1.69M |
|
$6.32M |
|
2.67M |
|
| Cash Flow Statement Financials | |
$-3.20M |
|
$0.00M |
|
$2.51M |
|
$0.73M |
|
$0.07M |
|
$-0.67M |
|
$0.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Tangible Equity |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|